Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Nanomedicine. 2019 Jul 15;21:102055. doi: 10.1016/j.nano.2019.102055

Fig. 4.2: Humoral OVA-specific antibody responses in mice vaccinated with different polyanhydride particle-based formulations containing OVA ± PELA.

Fig. 4.2:

(A) Serum titers of OVA-specific IgG1; (B) Serum titers of OVA-specific IgG2C; (C) IgG2C:IgG1 ratio. Data are plotted as mean ± SEM, n = 10. ***p<0.001.